The Alliance of Community Health Plans (ACHP) submitted a response to an RFI from the National Institute of Standards and Technology on the exercise of march-in rights. ACHP applauds the government-wide effort to ensure federal agencies are equipped with the necessary guidance and information to exercise march-in rights and secure the federal benefit owed to taxpayers. We strongly encourage the National Institutes of Health to use this framework to take action to utilize march-in rights to lower the cost of prescription drugs.
New from ACHP:
- ACHP Statement on Budget Reconciliation Bill
- ACHP Recommendations on Prescription Drug Machine-Readable File Requirement in Coverage Final Rule
- ACHP Opposes Senate Reconciliation Bill That Threatens Coverage for Millions
- ACHP Recommendations to Strengthen CMS Drug Price Negotiation Guidance for 2028
- GLP-1s Are Not A Silver Bullet
- Local Health Plans Meet Community Needs with Affordable, Accessible Vaccines
